Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-042501
Filing Date
2011-02-23
Accepted
2011-02-22 20:02:39
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1548395
2 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2978
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9241
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9256
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 4321
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 4336
7 GRAPHIC g152960g09j13.jpg GRAPHIC 26690
  Complete submission text file 0001193125-11-042501.txt   1617002
Mailing Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808
Business Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 49 6172 608 2327
Fresenius Kabi Pharmaceuticals Holding, Inc. (Filer) CIK: 0001439449 (see all company filings)

EIN.: 980589183 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34172 | Film No.: 11630243
SIC: 2834 Pharmaceutical Preparations